Enrique
Bernal Morell
Profesor Contratado Doctor Tipo a (Vinculado)
Publikationen (137) Publikationen von Enrique Bernal Morell
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study)
Open Forum Infectious Diseases, Vol. 11, Núm. 3
-
Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 6, pp. 553-561
-
HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation
Infectious Diseases
-
Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study
Critical care medicine, Vol. 52, Núm. 6, pp. 930-941
-
Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression
HIV Medicine, Vol. 25, Núm. 1, pp. 107-116
-
Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study
Open Forum Infectious Diseases, Vol. 11, Núm. 1
2023
-
A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Open Forum Infectious Diseases, Vol. 10, Núm. 11
-
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years
GeroScience, Vol. 45, Núm. 1, pp. 543-553
-
Correction: Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (Trials, (2021), 22, 1, (851), 10.1186/s13063-021-05777-6)
Trials
-
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
EBioMedicine, Vol. 95, pp. 104773
-
Failure of Non-Invasive Respiratory Support in Patients with SARS-CoV-2
Journal of Clinical Medicine, Vol. 12, Núm. 20
-
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors
Frontiers in Immunology, Vol. 14
-
Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach
Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 435-443
-
Remdesivir plus dexamethasone is associated to improvement in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status
Medicina Clinica, Vol. 161, Núm. 4, pp. 139-146
-
Role of vaccination and anti-SARS-CoV-2 antibodies in the clinical outcome of hospitalized COVID-19 patients
Medicina Clinica, Vol. 160, Núm. 11, pp. 476-483
-
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701
-
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses
BMC Infectious Diseases, Vol. 23, Núm. 1
-
Whole Sequencing and Detailed Analysis of SARS-CoV-2 Genomes in Southeast Spain: Identification of Recurrent Mutations in the 20E (EU1) Variant with Some Clinical Implications
Diseases, Vol. 11, Núm. 2